First Time Loading...

Merck KGaA
XETRA:MRK

Watchlist Manager
Merck KGaA Logo
Merck KGaA
XETRA:MRK
Watchlist
Price: 148.95 EUR -0.67%
Updated: May 1, 2024
Section:
 

Relative Value

The Relative Value of one MRK stock under the Base Case scenario is 191.42 EUR. Compared to the current market price of 148.95 EUR, Merck KGaA is Undervalued by 22%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

MRK Relative Value
Base Case
191.42 EUR
Undervaluation 22%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

3.1
P/S
P/S
Price to Sales
3.1
vs History
62
vs Industry
39
Median 3Y
3.4
Median 5Y
3.2
Industry
2.4
Forward
3
More Details
22.9
P/E
P/E
Price to Earnings
22.9
vs History
62
vs Industry
23
Median 3Y
23.8
Median 5Y
23.8
Industry
22.9
Forward
17.2
More Details
17.1
P/OCF
P/OCF
Price to OCF
17.1
vs History
45
vs Industry
25
Median 3Y
17.2
Median 5Y
16.9
Industry
17.1
More Details
54.3
P/FCFE
P/FCFE
Price to FCFE
54.3
vs History
24
vs Industry
11
Median 3Y
51
Median 5Y
39.8
Industry
23.2
More Details
2.4
P/B
P/B
Price to Book Value
2.4
vs History
75
vs Industry
34
Median 3Y
2.9
Median 5Y
2.7
Industry
2.1
More Details
3.4
EV/S
EV/S
Enterprise Value to Sales
3.4
vs History
66
vs Industry
35
Median 3Y
3.8
Median 5Y
3.6
Industry
2.6
Forward
3.3
More Details
5.7
EV/GP
EV/GP
Enterprise Value to Gross Profit
5.7
vs History
62
vs Industry
38
Median 3Y
6.1
Median 5Y
5.9
Industry
5.1
More Details
11.7
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
11.7
vs History
79
vs Industry
31
Median 3Y
12.9
Median 5Y
12.5
Industry
13.6
Forward
11.9
More Details
16.9
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
16.9
vs History
90
vs Industry
28
Median 3Y
18.7
Median 5Y
20.4
Industry
17
Forward
16.2
More Details
18.9
EV/OCF
EV/OCF
Enterprise Value to OCF
18.9
vs History
51
vs Industry
25
Median 3Y
19
Median 5Y
19
Industry
15.8
More Details
40.6
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
40.6
vs History
8
vs Industry
13
Median 3Y
32.6
Median 5Y
32.1
Industry
17.6
More Details
1.6
EV/IC
EV/IC
Enterprise Value to IC
1.6
vs History
61
vs Industry
43
Median 3Y
1.8
Median 5Y
1.7
Industry
1.9
More Details

Multiples Across Competitors

MRK Competitors Multiples
Merck KGaA Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
DE
Merck KGaA
XETRA:MRK
64.8B EUR 3.1 22.9 11.7 16.9
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
735.7B USD 21.6 140.7 63.4 72.7
DK
Novo Nordisk A/S
CSE:NOVO B
4T DKK 17.1 47.6 34.8 37.9
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
JP
Taisho Pharmaceutical Holdings Co Ltd
TSE:4581
82T JPY 255.8 9 733.7 1 771.8 4 320.3
US
Johnson & Johnson
NYSE:JNJ
360.8B USD 4.4 8.9 11.9 15.7
US
Merck & Co Inc
NYSE:MRK
326.9B USD 5.4 895.4 44.5 86.9
UK
AstraZeneca PLC
LSE:AZN
188.4B GBP 5.1 39.5 140.7 225.7
CH
Novartis AG
SIX:NOVN
182B CHF 4.2 13.3 9.7 16.1
CH
Roche Holding AG
SIX:ROG
175.9B CHF 3 15.3 8.7 10.3

See Also

Summary
MRK intrinsic value, competitors valuation, and company profile.
DCF Valuation
MRK stock valuation using Discount Cash Flow valuation method.
Relative Valuation
MRK stock valuation using valuation multiples.
Wall Street Estimates
MRK price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
MRK stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 133,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.